Viva Biotech Holdings (1873.HK)

HKD 1.52

(4.83%)

Operating Expenses Summary of Viva Biotech Holdings

Viva Biotech Holdings's latest annual operating expenses in 2023 was 545.74 Million CNY , down -56.62% from previous year.
Viva Biotech Holdings's latest quarterly operating expenses in 2024 Q2 was 217.59 Million CNY , down 0.0% from previous quarter.
Viva Biotech Holdings reported a annual operating expenses of 1.11 Billion CNY in annual operating expenses 2022, up 657.61% from previous year.
Viva Biotech Holdings reported a annual operating expenses of 146.74 Million CNY in annual operating expenses 2021, down -76.16% from previous year.
Viva Biotech Holdings reported a quarterly operating expenses of 482.3 Million CNY for 2023 FY, down -56.62% from previous quarter.
Viva Biotech Holdings reported a quarterly operating expenses of 294.57 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Viva Biotech Holdings (2023 - 2016)

Historical Annual Operating Expenses of Viva Biotech Holdings (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	545.74 Million CNY	-56.62%
2022	1.11 Billion CNY	657.61%
2021	146.74 Million CNY	-76.16%
2020	615.65 Million CNY	448.58%
2019	112.22 Million CNY	112127.0%
2018	100 Thousand CNY	-99.65%
2017	28.76 Million CNY	14.72%
2016	25.06 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	217.59 Million CNY	0.0%
2023 FY	482.3 Million CNY	-56.62%
2023 Q2	294.57 Million CNY	0.0%
2023 Q4	265.21 Million CNY	0.0%
2022 Q2	330.26 Million CNY	0.0%
2022 FY	1.11 Billion CNY	657.61%
2022 Q4	781.51 Million CNY	0.0%
2021 Q4	32.45 Million CNY	0.0%
2021 FY	146.74 Million CNY	-76.16%
2021 Q2	114.29 Million CNY	0.0%
2020 Q4	23.88 Million CNY	0.0%
2020 FY	615.65 Million CNY	448.58%
2020 Q2	591.76 Million CNY	0.0%
2019 Q4	131.08 Million CNY	0.0%
2019 Q2	18.85 Million CNY	0.0%
2019 FY	112.22 Million CNY	112127.0%
2018 Q4	17.72 Million CNY	0.0%
2018 FY	100 Thousand CNY	-99.65%
2018 Q2	17.82 Million CNY	0.0%
2017 Q1	7.19 Million CNY	0.0%
2017 FY	28.76 Million CNY	14.72%
2017 Q4	18.8 Million CNY	0.0%
2017 Q2	7.19 Million CNY	0.0%
2016 Q4	7.19 Million CNY	0.0%
2016 Q1	6.26 Million CNY	0.0%
2016 FY	25.06 Million CNY	0.0%
2016 Q2	6.26 Million CNY	0.0%
2015 Q4	6.26 Million CNY	0.0%

Peer Operating Expenses Comparison of Viva Biotech Holdings

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-67.897%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	26.176%